Abigail Chan is an Oncology physician. OpenAlex indexes 42 publications with 410 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
530 S Jackson St
Louisville, KY 402021675
Telephone
502-562-3000Provider last certified this registry record 22 Feb 2023.
Industry payments
47 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20256 payments
- Terumo Medical CorporationProgram year20251 payment
- Astellas Pharma US IncProgram year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
42.8%Opioid Agonist23.4%Oxycodone Hcl62%Oxycodone-Acetaminophen23%Morphine Sulfate Er14%Part D<11 patientsPhenothiazine10.1%Prochlorperazine Maleate100%Part D≥33 patients+ 3 more classes in this area
Metabolism & gastrointestinal
29.7%Serotonin-3 Receptor Antagonist13.7%Ondansetron Hcl82%Ondansetron Odt19%Part D<11 patientsAntidiarrheal4.2%Diphenoxylate-Atropine100%Part D≥11 patients+ 4 more classes in this area
Sensory organs
14.3%Corticosteroid14.3%Dexamethasone100%Part D≥32 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Managing suspected myasthenia gravis and myositis induced by pembrolizumab in a Jehovah's Witness sarcoma patient
Journal of Oncology Pharmacy Practice
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”